Comparative efficacy of GLP-1 RAs/SGLT-2 inhibitors in reducing cardiovascular events in type 2 diabetes according to baseline use of metformin: a systematic review and meta-analysis of randomized controlled trials

Comparative efficacy of GLP-1 RAs/SGLT-2 inhibitors in reducing cardiovascular events in type 2 diabetes according to baseline use of metformin: a systematic review and meta-analysis of randomized controlled trials

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of medical research 2025-01, Vol.30 (1), Article 13
Hauptverfasser: Zhang, Yuxin, Li, Zhaoji, Hao, Yongchen
Format: Artikel
Sprache:eng
Schlagworte:
Review
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page
container_title European journal of medical research
container_volume 30
creator Zhang, Yuxin
Li, Zhaoji
Hao, Yongchen
description
doi_str_mv 10.1186/s40001-024-02241-4
format Article
fullrecord <record><control><sourceid>pubmedcentral_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11706166</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_11706166</sourcerecordid><originalsourceid>FETCH-LOGICAL-c996-9b9b3230f2acb0e28e9422fa3c7a3b2f249aaf2bc087853297e28cabb72433693</originalsourceid><addsrcrecordid>eNpVUctuFDEQHCEiEYX8QE7-gSF-ZWbMBUUrWJBWAsEecrPannZiNGOvbO-g4UP5HrxZhODQ6lJ3VbWtapobRt8wNnS3WVJKWUu5rMUla-WL5pJT2bf9IB5e_oNfNdc5f69s2vGuV-qy-bWJ8wESFL8gQee8BbuS6Mh296Vl5Ot9vv223e1bTnx48saXmHKFJOF4tD48Egtp9HGBbI8TJIILhvLMKOsBCSejB4MFMwFrY6VWSYnEQMbJByTHjKdrMxYX0-zDWwIkr7ngXJ9k65nF4w8CYTxRoIUA05p9PmlSncbZ_8SR2BhKitNUYUkepvy6uXC14fWfftXsP7zfbz62u8_bT5v7XWuV6lpllBFcUMfBGop8QCU5dyBsD8Jwx6UCcNxYOvTDneCqrxwLxvRcCtEpcdW8O9sejmbG0da_J5j0IfkZ0qojeP3_Jvgn_RgXzVhPO9Z11YGfHWyKOSd0f8WM6lO6-pyurunq53S1FL8BCL-eIA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Comparative efficacy of GLP-1 RAs/SGLT-2 inhibitors in reducing cardiovascular events in type 2 diabetes according to baseline use of metformin: a systematic review and meta-analysis of randomized controlled trials</title><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>SpringerLink Journals - AutoHoldings</source><creator>Zhang, Yuxin ; Li, Zhaoji ; Hao, Yongchen</creator><creatorcontrib>Zhang, Yuxin ; Li, Zhaoji ; Hao, Yongchen</creatorcontrib><identifier>ISSN: 2047-783X</identifier><identifier>ISSN: 0949-2321</identifier><identifier>EISSN: 2047-783X</identifier><identifier>DOI: 10.1186/s40001-024-02241-4</identifier><language>eng</language><publisher>London: BioMed Central</publisher><subject>Review</subject><ispartof>European journal of medical research, 2025-01, Vol.30 (1), Article 13</ispartof><rights>The Author(s) 2024 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c996-9b9b3230f2acb0e28e9422fa3c7a3b2f249aaf2bc087853297e28cabb72433693</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11706166/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11706166/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27923,27924,53790,53792</link.rule.ids></links><search><creatorcontrib>Zhang, Yuxin</creatorcontrib><creatorcontrib>Li, Zhaoji</creatorcontrib><creatorcontrib>Hao, Yongchen</creatorcontrib><title>Comparative efficacy of GLP-1 RAs/SGLT-2 inhibitors in reducing cardiovascular events in type 2 diabetes according to baseline use of metformin: a systematic review and meta-analysis of randomized controlled trials</title><title>European journal of medical research</title><subject>Review</subject><issn>2047-783X</issn><issn>0949-2321</issn><issn>2047-783X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><recordid>eNpVUctuFDEQHCEiEYX8QE7-gSF-ZWbMBUUrWJBWAsEecrPannZiNGOvbO-g4UP5HrxZhODQ6lJ3VbWtapobRt8wNnS3WVJKWUu5rMUla-WL5pJT2bf9IB5e_oNfNdc5f69s2vGuV-qy-bWJ8wESFL8gQee8BbuS6Mh296Vl5Ot9vv223e1bTnx48saXmHKFJOF4tD48Egtp9HGBbI8TJIILhvLMKOsBCSejB4MFMwFrY6VWSYnEQMbJByTHjKdrMxYX0-zDWwIkr7ngXJ9k65nF4w8CYTxRoIUA05p9PmlSncbZ_8SR2BhKitNUYUkepvy6uXC14fWfftXsP7zfbz62u8_bT5v7XWuV6lpllBFcUMfBGop8QCU5dyBsD8Jwx6UCcNxYOvTDneCqrxwLxvRcCtEpcdW8O9sejmbG0da_J5j0IfkZ0qojeP3_Jvgn_RgXzVhPO9Z11YGfHWyKOSd0f8WM6lO6-pyurunq53S1FL8BCL-eIA</recordid><startdate>20250107</startdate><enddate>20250107</enddate><creator>Zhang, Yuxin</creator><creator>Li, Zhaoji</creator><creator>Hao, Yongchen</creator><general>BioMed Central</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20250107</creationdate><title>Comparative efficacy of GLP-1 RAs/SGLT-2 inhibitors in reducing cardiovascular events in type 2 diabetes according to baseline use of metformin: a systematic review and meta-analysis of randomized controlled trials</title><author>Zhang, Yuxin ; Li, Zhaoji ; Hao, Yongchen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c996-9b9b3230f2acb0e28e9422fa3c7a3b2f249aaf2bc087853297e28cabb72433693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Yuxin</creatorcontrib><creatorcontrib>Li, Zhaoji</creatorcontrib><creatorcontrib>Hao, Yongchen</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>European journal of medical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Yuxin</au><au>Li, Zhaoji</au><au>Hao, Yongchen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparative efficacy of GLP-1 RAs/SGLT-2 inhibitors in reducing cardiovascular events in type 2 diabetes according to baseline use of metformin: a systematic review and meta-analysis of randomized controlled trials</atitle><jtitle>European journal of medical research</jtitle><date>2025-01-07</date><risdate>2025</risdate><volume>30</volume><issue>1</issue><artnum>13</artnum><issn>2047-783X</issn><issn>0949-2321</issn><eissn>2047-783X</eissn><cop>London</cop><pub>BioMed Central</pub><doi>10.1186/s40001-024-02241-4</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2047-783X
ispartof European journal of medical research, 2025-01, Vol.30 (1), Article 13
issn 2047-783X
0949-2321
2047-783X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11706166
source DOAJ Directory of Open Access Journals; PubMed Central Open Access; Springer Nature OA Free Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; SpringerLink Journals - AutoHoldings
subjects Review
title Comparative efficacy of GLP-1 RAs/SGLT-2 inhibitors in reducing cardiovascular events in type 2 diabetes according to baseline use of metformin: a systematic review and meta-analysis of randomized controlled trials
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T09%3A49%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparative%20efficacy%20of%20GLP-1%20RAs/SGLT-2%20inhibitors%20in%20reducing%20cardiovascular%20events%20in%20type%202%20diabetes%20according%20to%20baseline%20use%20of%20metformin:%20a%20systematic%20review%20and%20meta-analysis%20of%20randomized%20controlled%20trials&rft.jtitle=European%20journal%20of%20medical%20research&rft.au=Zhang,%20Yuxin&rft.date=2025-01-07&rft.volume=30&rft.issue=1&rft.artnum=13&rft.issn=2047-783X&rft.eissn=2047-783X&rft_id=info:doi/10.1186/s40001-024-02241-4&rft_dat=%3Cpubmedcentral_cross%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_11706166%3C/pubmedcentral_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true